{"title":"心肾综合征(CRS)","authors":"Enrico V. Scabbia, Luca Scabbia","doi":"10.1016/j.ijcme.2014.10.013","DOIUrl":null,"url":null,"abstract":"<div><p>The presence of impaired kidney function during heart failure and vice versa is a frequent occurrence. This situation is defined “Cardio-renal Syndrome”.</p><p>In the Cardio-renal Syndrome (CRS) are included 5 different sub-syndromes defined on the basis of the organ primitively responsible: Acute Cardio-renal Syndrome (Type 1), Chronic Cardio-renal Syndrome (Type 2), Acute Reno-cardiac Syndrome (Type 3), Chronic Renal-cardiac Syndrome (Type 4) and Secondary Cardio-renal Syndrome (Type 5).</p><p>The physiopathologic mechanisms underlying CRS are still partially obscure, but, a key role seems to be played by the renin-angiotensin-aldosterone axis.</p><p>Therapeutic strategies involved in CRS treatment include the use of diuretics, ACE inhibitors, Angiotensin Receptor Blockers and β-Blockers, emphasizing the role of a proper use of medication indicated for the treatment of cardiac decompensation.</p></div>","PeriodicalId":73333,"journal":{"name":"IJC metabolic & endocrine","volume":"9 ","pages":"Pages 1-4"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ijcme.2014.10.013","citationCount":"4","resultStr":"{\"title\":\"The Cardio-renal Syndrome (CRS)\",\"authors\":\"Enrico V. Scabbia, Luca Scabbia\",\"doi\":\"10.1016/j.ijcme.2014.10.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The presence of impaired kidney function during heart failure and vice versa is a frequent occurrence. This situation is defined “Cardio-renal Syndrome”.</p><p>In the Cardio-renal Syndrome (CRS) are included 5 different sub-syndromes defined on the basis of the organ primitively responsible: Acute Cardio-renal Syndrome (Type 1), Chronic Cardio-renal Syndrome (Type 2), Acute Reno-cardiac Syndrome (Type 3), Chronic Renal-cardiac Syndrome (Type 4) and Secondary Cardio-renal Syndrome (Type 5).</p><p>The physiopathologic mechanisms underlying CRS are still partially obscure, but, a key role seems to be played by the renin-angiotensin-aldosterone axis.</p><p>Therapeutic strategies involved in CRS treatment include the use of diuretics, ACE inhibitors, Angiotensin Receptor Blockers and β-Blockers, emphasizing the role of a proper use of medication indicated for the treatment of cardiac decompensation.</p></div>\",\"PeriodicalId\":73333,\"journal\":{\"name\":\"IJC metabolic & endocrine\",\"volume\":\"9 \",\"pages\":\"Pages 1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ijcme.2014.10.013\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IJC metabolic & endocrine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214762414000553\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJC metabolic & endocrine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214762414000553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The presence of impaired kidney function during heart failure and vice versa is a frequent occurrence. This situation is defined “Cardio-renal Syndrome”.
In the Cardio-renal Syndrome (CRS) are included 5 different sub-syndromes defined on the basis of the organ primitively responsible: Acute Cardio-renal Syndrome (Type 1), Chronic Cardio-renal Syndrome (Type 2), Acute Reno-cardiac Syndrome (Type 3), Chronic Renal-cardiac Syndrome (Type 4) and Secondary Cardio-renal Syndrome (Type 5).
The physiopathologic mechanisms underlying CRS are still partially obscure, but, a key role seems to be played by the renin-angiotensin-aldosterone axis.
Therapeutic strategies involved in CRS treatment include the use of diuretics, ACE inhibitors, Angiotensin Receptor Blockers and β-Blockers, emphasizing the role of a proper use of medication indicated for the treatment of cardiac decompensation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
